VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — Sable Resources Ltd. (“Sable” or the “Company”) (TSXV:SAE | OTCQB:SBLRF) is pleased to announce that it has received preliminary results from its ongoing exploration campaign at the Perk Rocky project in British Columbia. Dr. Ruben Padilla, President and CEO of Sable, stated, “Sable’s team undertook a […]

LOS ANGELES, Sept. 19, 2024 (GLOBE NEWSWIRE) — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that positive results from the company’s global Phase 3 clinical trial of izokibep in moderate-to-severe hidradenitis suppurativa (HS) patients will be shared as a

ONTARIO, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Heritage Grocers Group (“Heritage” or “HGG”), one of the leading Hispanic food retailers in the country, is pleased to announce its portfolio of companies that includes Cardenas Markets, El Rancho Supermercado and Tony’s Fresh Market has officially kicked off a series of initiatives to celebrate Hispanic Heritage

PLANO, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Today, European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the largest and fastest-growing franchisor and operator of out-of-home waxing services in the United States, announced several strategic Commercial and Operational updates as the Company continues to focus on its key initiatives of attracting

SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Girard Sharp LLP and The Hall Firm, Ltd., both national law firms specializing in complex class actions and shareholder rights, announce they have filed a class action lawsuit for violations of the federal securities laws against Orthofix Medical Inc. (“Orthofix” or “Company”) (NASDAQ: OFIX) and certain current

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia Submitted protocol to FDA for TRANQUILITY In-Care pivotal Phase 3 trial for agitation associated with Alzheimer’s dementia Company to maintain IGALMI(TM) in the market without current commercial infrastructure NEW HAVEN, Conn., Sept. 19, 2024 (GLOBE NEWSWIRE) — — BioXcel

BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Today, the Addiction Policy Forum released new fentanyl awareness resources available in 12 languages to help increase knowledge of fentanyl-related overdose risks. The project is supported by the Cencora Impact Foundation and the Ethnic Communities Opioids Response Network – Missouri (ECORN-MO) to provide open-source, science-backed prevention materials

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre”; TSXâ?V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the Company”) today announced a partnership with VRIFY which incorporates VRIFY’s cutting-edge Artificial Intelligence (“AI”) mineral targeting platform. This partnership aims to both accelerate and enhance the mineral discovery process by taking an unbiased data-driven approach

BETHESDA, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced presentations, including two late-breakers, at Neuroscience 2024 featuring preclinical data supporting development of GT-02287, the Company’s clinical stage

New patent expected to expire in 2030 Tosymra(R) (sumatriptan nasal spray) 10mg is indicated and marketed for the acute treatment of migraine in adults CHATHAM, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates,